Li J - Search Results

1

In vitro and in vivo evaluation of puerarin-loaded PEGylated mesoporous silica nanoparticles.

Liu X, Ding Y, Zhao B, Liu Y, Luo S, Wu J, Li J, Xiang D. Liu X, et al. Among authors: li j. Drug Dev Ind Pharm. 2016 Dec;42(12):2031-2037. doi: 10.1080/03639045.2016.1190742. Epub 2016 Jun 9. Drug Dev Ind Pharm. 2016. PMID: 27282345

2

[Stability of PEGylated puerarin under different storage conditions].

Liu XY, Xiang DX, Li JH, Hu XB, Ye ZG. Liu XY, et al. Zhongguo Zhong Yao Za Zhi. 2012 Nov;37(22):3391-4. Zhongguo Zhong Yao Za Zhi. 2012. PMID: 23373208 Chinese.

3

[In vitro dissolution of forsythin in Forsythia suspensa powder of different particle diameter].

Liu XY, Zhang SH, Li JH, Xiang DX, Yi LD, Ye ZG. Liu XY, et al. Zhongguo Zhong Yao Za Zhi. 2012 Nov;37(21):3233-5. Zhongguo Zhong Yao Za Zhi. 2012. PMID: 23397719 Chinese.

4

[Protective effect of yixinshu capsule on myocardial ischemia reperfusion injury in rats].

Liu JW, Liu XY, Li JH, Xiang DX, Yi LD, Hu XB, Ye ZG. Liu JW, et al. Zhongguo Zhong Yao Za Zhi. 2013 Jun;38(12):2005-8. Zhongguo Zhong Yao Za Zhi. 2013. PMID: 24066601 Chinese.

5

Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile.

Li W, Wu J, Zhang J, Wang J, Xiang D, Luo S, Li J, Liu X. Li W, et al. Among authors: li j. Drug Deliv. 2018 Nov;25(1):827-837. doi: 10.1080/10717544.2018.1455763. Drug Deliv. 2018. PMID: 29587545 Free PMC article.

6

Piperazine ferulate ameliorates the development of diabetic nephropathy by regulating endothelial nitric oxide synthase.

Yang YY, Shi LX, Li JH, Yao LY, Xiang DX. Yang YY, et al. Mol Med Rep. 2019 Mar;19(3):2245-2253. doi: 10.3892/mmr.2019.9875. Epub 2019 Jan 17. Mol Med Rep. 2019. PMID: 30664213 Free PMC article.

7

[In vitro evaluation, cellular uptake and anti-acute myocardial ischemia effect of puerarin PEG-PLGA micelles].

Liu XY, Jiang ZB, Luo J, Li JH, Hu XB. Liu XY, et al. Among authors: li jh. Zhongguo Zhong Yao Za Zhi. 2019 Jun;44(11):2244-2250. doi: 10.19540/j.cnki.cjcmm.20190321.302. Zhongguo Zhong Yao Za Zhi. 2019. PMID: 31359649 Chinese.

8

A trial-based cost-effectiveness analysis of erlotinib alone versus platinum-based doublet chemotherapy as first-line therapy for Eastern Asian nonsquamous non-small-cell lung cancer.

Wang S, Peng L, Li J, Zeng X, Ouyang L, Tan C, Lu Q. Wang S, et al. Among authors: li j. PLoS One. 2013;8(3):e55917. doi: 10.1371/journal.pone.0055917. Epub 2013 Mar 8. PLoS One. 2013. PMID: 23520448 Free PMC article. Clinical Trial.

9

Economic evaluation of first-line adjuvant chemotherapies for resectable gastric cancer patients in China.

Tan C, Peng L, Zeng X, Li J, Wan X, Chen G, Yi L, Luo X, Zhao Z. Tan C, et al. Among authors: li j. PLoS One. 2013 Dec 10;8(12):e83396. doi: 10.1371/journal.pone.0083396. eCollection 2013. PLoS One. 2013. PMID: 24340099 Free PMC article.

10

Economic outcomes of maintenance gefitinib for locally advanced/metastatic non-small-cell lung cancer with unknown EGFR mutations: a semi-Markov model analysis.

Zeng X, Li J, Peng L, Wang Y, Tan C, Chen G, Wan X, Lu Q, Yi L. Zeng X, et al. Among authors: li j. PLoS One. 2014 Feb 20;9(2):e88881. doi: 10.1371/journal.pone.0088881. eCollection 2014. PLoS One. 2014. PMID: 24586426 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195,440 results

Search Page

Filters